Call 1 (888) 460-6556 to speak with a counselor.

Updated Date: Sep 4, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

{ Comments on this entry are closed }

Call 1 (888) 460-6556 to speak with a counselor.

ConclusionsThis performance comparison of three missing data strategies (latent growth model, Diggle‐Kenward selection model, Wu‐Carrol selection model) on sample data indicates a need for increased use of sensitivity analyses in clinical trial research. Given the potential sensitivity of the trial arm effect to missing data assumptions, it is critical for researchers to consider whether the assumptions associated with each model are defensible. (Source: Addiction)

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

{ Comments on this entry are closed }

Buprenorphine and buprenorphine/naloxone intoxication in children – how strong is the risk? – Soyka M.

August 14, 2014

Opioid maintenance therapy with methadone or buprenorphine is an established and first-line treatment for opioid dependence. Risk of diversion and toxicity of opioid prescription drugs, including buprenorphine, causes significant concerns. This is particul… (Source: SafetyLit: All (Unduplicated)) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →

BUNAVAIL (Buprenorphine And Naloxone) Film [BioDelivery Sciences International, Inc.]

August 6, 2014

Updated Date: Aug 6, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →

The multi-site Prescription Opioid Addiction Treatment Study: 18-month outcomes

August 1, 2014

Despite the high prevalence of prescription opioid dependence in the U.S., little is known about the course of this disorder and long-term response to treatment. We therefore examined 18-month post-randomization outcomes of participants in the Prescription Opioid Addiction Treatment Study, a multi-site, randomized controlled trial examining varying durations of buprenorphine-naloxone treatment and different intensities of […]

Read the full article →

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine‐maintained heroin users

July 23, 2014

Abstract In spite of the clinical utility of buprenorphine, parenteral abuse of this medication has been reported in several laboratory investigations and in the real world. Studies have demonstrated lower abuse liability of the buprenorphine/naloxone combination relative to buprenorphine alone. However, clinical research has not yet examined the utility of the combined formulation to deter […]

Read the full article →

Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone(®) for chronic pain: a case report.

July 1, 2014

CONCLUSION: In a chronic pain patient continued on Suboxone perioperatively, significant improvement in control of postoperative pain was observed following tapered doses, and eventually her use of Suboxone was discontinued. This case highlights the potential for opioid receptor blockade by Suboxone, which can interfere with acute pain management. PMID: 24985936 [PubMed – as supplied by […]

Read the full article →

Naltrexone implant treatment for buprenorphine dependence – Mauritian case series

July 1, 2014

Although substitution therapy with opiate agonist treatments such as methadone and buprenorphine has resulted in a reduction of illicit drug use related harm, such treatment has also resulted in severe problems in some countries where opioid-dependent individuals now inject illicitly sold buprenorphine or buprenorphine-naloxone instead of heroin. There is no approved treatment for buprenorphine dependence. […]

Read the full article →

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE Tablet [Roxane Laboratories, Inc.]

June 30, 2014

Updated Date: Jun 30, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →

Positive Results With Combo Tx for Opioid Dependence Positive Results With Combo Tx for Opioid Dependence

June 24, 2014

Orexo AB announced new topline results of 2 clinical trials with a combination of buprenorphine and naloxone for buprenorphine induction and plans to pursue approval of an expanded label in the US. Medscape Medical News (Source: Medscape Medical News Headlines) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →